Psomagen Balance Sheet Health
Financial Health criteria checks 5/6
Psomagen has a total shareholder equity of ₩31.3B and total debt of ₩518.6M, which brings its debt-to-equity ratio to 1.7%. Its total assets and total liabilities are ₩50.1B and ₩18.8B respectively.
Key information
1.7%
Debt to equity ratio
₩518.59m
Debt
| Interest coverage ratio | n/a |
| Cash | ₩10.75b |
| Equity | ₩31.32b |
| Total liabilities | ₩18.82b |
| Total assets | ₩50.14b |
Financial Position Analysis
Short Term Liabilities: A950200's short term assets (₩23.1B) exceed its short term liabilities (₩10.9B).
Long Term Liabilities: A950200's short term assets (₩23.1B) exceed its long term liabilities (₩7.9B).
Debt to Equity History and Analysis
Debt Level: A950200 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if A950200's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A950200 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A950200 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 21.9% each year